{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:39:15Z","timestamp":1778870355658,"version":"3.51.4"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,10,26]],"date-time":"2014-10-26T00:00:00Z","timestamp":1414281600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s10822-014-9809-0","type":"journal-article","created":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T11:30:37Z","timestamp":1414236637000},"page":"127-141","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proteochemometric model for predicting the inhibition of penicillin-binding proteins"],"prefix":"10.1007","volume":"29","author":[{"given":"Sunanta","family":"Nabu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chanin","family":"Nantasenamat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wiwat","family":"Owasirikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratana","family":"Lawung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chartchalerm","family":"Isarankura-Na-Ayudhya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maris","family":"Lapins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jarl E. S.","family":"Wikberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virapong","family":"Prachayasittikul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,10,26]]},"reference":[{"key":"9809_CR1","volume-title":"Global incidence and prevalence of selected curable sexually transmitted infections","author":"World Health Organization","year":"2008","unstructured":"World Health Organization (2008) Global incidence and prevalence of selected curable sexually transmitted infections. World Health Organization, Geneva"},{"issue":"1","key":"9809_CR2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/QCO.0b013e328320a836","volume":"22","author":"JW Tapsall","year":"2009","unstructured":"Tapsall JW (2009) Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis 22(1):87\u201391","journal-title":"Curr Opin Infect Dis"},{"issue":"10","key":"9809_CR3","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1128\/AAC.37.10.2045","volume":"37","author":"NH Georgopapadakou","year":"1993","unstructured":"Georgopapadakou NH (1993) Penicillin-binding proteins and bacterial resistance to beta-lactams. Antimicrob Agents Chemother 37(10):2045\u20132053","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9809_CR4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1574-6976.2007.00095.x","volume":"32","author":"A Zapun","year":"2008","unstructured":"Zapun A, Contreras-Martel C, Vernet T (2008) Penicillin-binding proteins and beta-lactam resistance. FEMS Microbiol Rev 32(2):361\u2013385","journal-title":"FEMS Microbiol Rev"},{"issue":"2","key":"9809_CR5","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1074\/jbc.M805761200","volume":"284","author":"AJ Powell","year":"2009","unstructured":"Powell AJ, Tomberg J, Deacon AM, Nicholas RA, Davies C (2009) Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistance. J Biol Chem 284(2):1202\u20131212","journal-title":"J Biol Chem"},{"issue":"2","key":"9809_CR6","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.19.2.316","volume":"19","author":"AG Barbour","year":"1981","unstructured":"Barbour AG (1981) Properties of penicillin-binding proteins in Neisseria gonorrhoeae. Antimicrob Agents Chemother 19(2):316\u2013322","journal-title":"Antimicrob Agents Chemother"},{"issue":"12","key":"9809_CR7","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.46.12.3744-3749.2002","volume":"46","author":"S Ameyama","year":"2002","unstructured":"Ameyama S, Onodera S, Takahata M, Minami S, Maki N, Endo K, Goto H, Suzuki H, Oishi Y (2002) Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime. Antimicrob Agents Chemother 46(12):3744\u20133749","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"9809_CR8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1093\/jac\/dkm166","volume":"60","author":"S Ochiai","year":"2007","unstructured":"Ochiai S, Sekiguchi S, Hayashi A, Shimadzu M, Ishiko H, Matsushima-Nishiwaki R, Kozawa O, Yasuda M, Deguchi T (2007) Decreased affinity of mosaic-structure recombinant penicillin-binding protein 2 for oral cephalosporins in Neisseria gonorrhoeae. J Antimicrob Chemother 60(1):54\u201360","journal-title":"J Antimicrob Chemother"},{"issue":"11","key":"9809_CR9","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1128\/AAC.00626-06","volume":"50","author":"S Takahata","year":"2006","unstructured":"Takahata S, Senju N, Osaki Y, Yoshida T, Ida T (2006) Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae. Antimicrob Agents Chemother 50(11):3638\u20133645","journal-title":"Antimicrob Agents Chemother"},{"issue":"37","key":"9809_CR10","doi-asserted-by":"crossref","first-page":"8062","DOI":"10.1021\/bi101167x","volume":"49","author":"J Tomberg","year":"2010","unstructured":"Tomberg J, Unemo M, Davies C, Nicholas RA (2010) Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations. Biochemistry 49(37):8062\u20138070","journal-title":"Biochemistry"},{"issue":"9","key":"9809_CR11","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1128\/AAC.00306-07","volume":"51","author":"DM Whiley","year":"2007","unstructured":"Whiley DM, Limnios EA, Ray S, Sloots TP, Tapsall JW (2007) Diversity of penA alterations and subtypes in Neisseria gonorrhoeae strains from Sydney, Australia, that are less susceptible to ceftriaxone. Antimicrob Agents Chemother 51(9):3111\u20133116","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9809_CR12","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s10156-008-0610-7","volume":"14","author":"K Osaka","year":"2008","unstructured":"Osaka K, Takakura T, Narukawa K, Takahata M, Endo K, Kiyota H, Onodera S (2008) Analysis of amino acid sequences of penicillin-binding protein 2 in clinical isolates of Neisseria gonorrhoeae with reduced susceptibility to cefixime and ceftriaxone. J Infect Chemother 14(3):195\u2013203","journal-title":"J Infect Chemother"},{"issue":"4","key":"9809_CR13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/jac\/dkp505","volume":"65","author":"SG Lee","year":"2010","unstructured":"Lee SG, Lee H, Jeong SH, Yong D, Chung GT, Lee YS, Chong Y, Lee K (2010) Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone. J Antimicrob Chemother 65(4):669\u2013675","journal-title":"J Antimicrob Chemother"},{"issue":"5","key":"9809_CR14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/jac\/dkr021","volume":"66","author":"M Liao","year":"2011","unstructured":"Liao M, Gu WM, Yang Y, Dillon JA (2011) Analysis of mutations in multiple loci of Neisseria gonorrhoeae isolates reveals effects of PIB, PBP2 and MtrR on reduced susceptibility to ceftriaxone. J Antimicrob Chemother 66(5):1016\u20131023","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"9809_CR15","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/jac\/dkq187","volume":"65","author":"DM Whiley","year":"2010","unstructured":"Whiley DM, Goire N, Lambert SB, Ray S, Limnios EA, Nissen MD, Sloots TP, Tapsall JW (2010) Reduced susceptibility to ceftriaxone in Neisseria gonorrhoeae is associated with mutations G542S, P551S and P551L in the gonococcal penicillin-binding protein 2. J Antimicrob Chemother 65(8):1615\u20131618","journal-title":"J Antimicrob Chemother"},{"key":"9809_CR16","first-page":"74","volume":"8","author":"C Nantasenamat","year":"2009","unstructured":"Nantasenamat C, Isarankura-Na-Ayudhya C, Naenna T, Prachayasittikul V (2009) A practical overview of quantitative structure-activity relationship. Excli J 8:74\u201388","journal-title":"Excli J"},{"issue":"7","key":"9809_CR17","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1517\/17460441.2010.492827","volume":"5","author":"C Nantasenamat","year":"2010","unstructured":"Nantasenamat C, Isarankura-Na-Ayudhya C, Prachayasittikul V (2010) Advances in computational methods to predict the biological activity of compounds. Expert Opin Drug Discov 5(7):633\u2013654","journal-title":"Expert Opin Drug Discov"},{"issue":"4","key":"9809_CR18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cbpa.2010.06.166","volume":"14","author":"JT Metz","year":"2010","unstructured":"Metz JT, Hajduk PJ (2010) Rational approaches to targeted polypharmacology: creating and navigating protein\u2013ligand interaction networks. Curr Opin Chem Biol 14(4):498\u2013504","journal-title":"Curr Opin Chem Biol"},{"issue":"6","key":"9809_CR19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/cmdc.200700026","volume":"2","author":"A Bender","year":"2007","unstructured":"Bender A, Scheiber J, Glick M, Davies JW, Azzaoui K, Hamon J, Urban L, Whitebread S, Jenkins JL (2007) Analysis of pharmacology data and the prediction of adverse drug reactions and off-target effects from chemical structure. Chem Med Chem 2(6):861\u2013873","journal-title":"Chem Med Chem"},{"issue":"1\u20132","key":"9809_CR20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S0167-4838(00)00249-1","volume":"1544","author":"P Prusis","year":"2001","unstructured":"Prusis P, Muceniece R, Andersson P, Post C, Lundstedt T, Wikberg JE (2001) PLS modeling of chimeric MS04\/MSH-peptide and MC1\/MC3-receptor interactions reveals a novel method for the analysis of ligand\u2013receptor interactions. Biochim Biophys Acta 1544(1\u20132):350\u2013357","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"9809_CR21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0304-4165(00)00187-2","volume":"1525","author":"M Lapinsh","year":"2001","unstructured":"Lapinsh M, Prusis P, Gutcaits A, Lundstedt T, Wikberg JE (2001) Development of proteo-chemometrics: a novel technology for the analysis of drug\u2013receptor interactions. Biochim Biophys Acta 1525(1\u20132):180\u2013190","journal-title":"Biochim Biophys Acta"},{"key":"9809_CR22","volume-title":"Chemogenomics in drug discovery\u2014a medicinal chemistry perspective","author":"JE Wikberg","year":"2004","unstructured":"Wikberg JE, Lapins M, Prusis P (2004) Proteochemometrics: a tool for modeling the molecular interaction space. In: Kubinyi H, M\u00fcller G (eds) Chemogenomics in drug discovery\u2014a medicinal chemistry perspective. Wiley-VCH, Weinheim"},{"issue":"1","key":"9809_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1039\/C0MD00165A","volume":"2","author":"GJP Westen van","year":"2011","unstructured":"van Westen GJP, Wegner JK, Ijzerman AP, van Vlijmen HWT, Bender A (2011) Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets. Med Chem Commun 2(1):16\u201330","journal-title":"Med Chem Commun"},{"key":"9809_CR24","volume-title":"Computational approaches in cheminformatics and bioinformatics","author":"JE Wikberg","year":"2012","unstructured":"Wikberg JE, Spjuth O, Eklund M, Lapins M (2012) Chemoinformatics taking biology into account: proteochemometrics. In: Guha R, Bender A (eds) Computational approaches in cheminformatics and bioinformatics. Wiley, Hoboken"},{"key":"9809_CR25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/1471-2105-7-167","volume":"7","author":"P Prusis","year":"2006","unstructured":"Prusis P, Uhlen S, Petrovska R, Lapinsh M, Wikberg JE (2006) Prediction of indirect interactions in proteins. BMC Bioinform 7:167","journal-title":"BMC Bioinform"},{"issue":"1","key":"9809_CR26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1002\/prot.21461","volume":"69","author":"A Kontijevskis","year":"2007","unstructured":"Kontijevskis A, Petrovska R, Mutule I, Uhlen S, Komorowski J, Prusis P, Wikberg JE (2007) Proteochemometric analysis of small cyclic peptides\u2019 interaction with wild-type and chimeric melanocortin receptors. Proteins 69(1):83\u201396","journal-title":"Proteins"},{"issue":"1","key":"9809_CR27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/mol.104.002857","volume":"67","author":"M Lapinsh","year":"2005","unstructured":"Lapinsh M, Veiksina S, Uhlen S, Petrovska R, Mutule I, Mutulis F, Yahorava S, Prusis P, Wikberg JE (2005) Proteochemometric mapping of the interaction of organic compounds with melanocortin receptor subtypes. Mol Pharmacol 67(1):50\u201359","journal-title":"Mol Pharmacol"},{"issue":"3","key":"9809_CR28","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1002\/prot.21323","volume":"67","author":"M Lapinsh","year":"2007","unstructured":"Lapinsh M, Prusis P, Petrovska R, Uhlen S, Mutule I, Veiksina S, Wikberg JE (2007) Proteochemometric modeling reveals the interaction site for Trp9 modified alpha-MSH peptides in melanocortin receptors. Proteins 67(3):653\u2013660","journal-title":"Proteins"},{"issue":"6","key":"9809_CR29","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1124\/mol.61.6.1465","volume":"61","author":"M Lapinsh","year":"2002","unstructured":"Lapinsh M, Prusis P, Lundstedt T, Wikberg JE (2002) Proteochemometrics modeling of the interaction of amine G-protein coupled receptors with a diverse set of ligands. Mol Pharmacol 61(6):1465\u20131475","journal-title":"Mol Pharmacol"},{"issue":"23","key":"9809_CR30","doi-asserted-by":"crossref","first-page":"4289","DOI":"10.1093\/bioinformatics\/bti703","volume":"21","author":"M Lapinsh","year":"2005","unstructured":"Lapinsh M, Prusis P, Uhlen S, Wikberg JE (2005) Improved approach for proteochemometrics modeling: application to organic compound\u2013amine G protein-coupled receptor interactions. Bioinformatics 21(23):4289\u20134296","journal-title":"Bioinformatics"},{"key":"9809_CR31","doi-asserted-by":"crossref","unstructured":"Lapins M, Worachartcheewan A, Spjuth O, Georgiev V, Prachayasittikul V, Nantasenamat C, Wikberg JES (2013) A unified proteochemometric model for prediction of inhibition of cytochrome P450 isoforms. PLoS One 8(6):e66566","DOI":"10.1371\/journal.pone.0066566"},{"issue":"9","key":"9809_CR32","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1021\/ci8000953","volume":"48","author":"A Kontijevskis","year":"2008","unstructured":"Kontijevskis A, Komorowski J, Wikberg JE (2008) Generalized proteochemometric model of multiple cytochrome p450 enzymes and their inhibitors. J Chem Inf Model 48(9):1840\u20131850","journal-title":"J Chem Inf Model"},{"key":"9809_CR33","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1471-2105-11-339","volume":"11","author":"M Lapins","year":"2010","unstructured":"Lapins M, Wikberg JE (2010) Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques. BMC Bioinform 11:339","journal-title":"BMC Bioinform"},{"issue":"20","key":"9809_CR34","doi-asserted-by":"crossref","first-page":"9369","DOI":"10.1016\/j.bmc.2008.08.081","volume":"16","author":"P Prusis","year":"2008","unstructured":"Prusis P, Lapins M, Yahorava S, Petrovska R, Niyomrattanakit P, Katzenmeier G, Wikberg JE (2008) Proteochemometrics analysis of substrate interactions with dengue virus NS3 proteases. Bioorg Med Chem 16(20):9369\u20139377","journal-title":"Bioorg Med Chem"},{"key":"9809_CR35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/1471-2105-13-212","volume":"13","author":"D Wu","year":"2012","unstructured":"Wu D, Huang Q, Zhang Y, Zhang Q, Liu Q, Gao J, Cao Z, Zhu R (2012) Screening of selective histone deacetylase inhibitors by proteochemometric modeling. BMC Bioinform 13:212","journal-title":"BMC Bioinform"},{"issue":"16","key":"9809_CR36","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/bioinformatics\/btq324","volume":"26","author":"I Dimitrov","year":"2010","unstructured":"Dimitrov I, Garnev P, Flower DR, Doytchinova I (2010) EpiTOP\u2014a proteochemometric tool for MHC class II binding prediction. Bioinformatics 26(16):2066\u20132068","journal-title":"Bioinformatics"},{"key":"9809_CR37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/1471-2105-9-181","volume":"9","author":"M Lapins","year":"2008","unstructured":"Lapins M, Eklund M, Spjuth O, Prusis P, Wikberg JE (2008) Proteochemometric modeling of HIV protease susceptibility. BMC Bioinform 9:181","journal-title":"BMC Bioinform"},{"issue":"5","key":"9809_CR38","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1021\/ci800453k","volume":"49","author":"M Lapins","year":"2009","unstructured":"Lapins M, Wikberg JE (2009) Proteochemometric modeling of drug resistance over the mutational space for multiple HIV protease variants and multiple protease inhibitors. J Chem Inf Model 49(5):1202\u20131210","journal-title":"J Chem Inf Model"},{"issue":"7","key":"9809_CR39","doi-asserted-by":"crossref","first-page":"e41698","DOI":"10.1371\/journal.pone.0041698","volume":"7","author":"Q Huang","year":"2012","unstructured":"Huang Q, Jin H, Liu Q, Wu Q, Kang H, Cao Z, Zhu R (2012) Proteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein\u2013ligand interaction fingerprint. PLoS One 7(7):e41698","journal-title":"PLoS One"},{"issue":"12","key":"9809_CR40","doi-asserted-by":"crossref","first-page":"e14353","DOI":"10.1371\/journal.pone.0014353","volume":"5","author":"M Junaid","year":"2010","unstructured":"Junaid M, Lapins M, Eklund M, Spjuth O, Wikberg JE (2010) Proteochemometric modeling of the susceptibility of mutated variants of the HIV-1 virus to reverse transcriptase inhibitors. PLoS One 5(12):e14353","journal-title":"PLoS One"},{"issue":"1","key":"9809_CR41","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1128\/AAC.49.1.137-143.2005","volume":"49","author":"M Ito","year":"2005","unstructured":"Ito M, Deguchi T, Mizutani KS, Yasuda M, Yokoi S, Ito S, Takahashi Y, Ishihara S, Kawamura Y, Ezaki T (2005) Emergence and spread of Neisseria gonorrhoeae clinical isolates harboring mosaic-like structure of penicillin-binding protein 2 in Central Japan. Antimicrob Agents Chemother 49(1):137\u2013143","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"9809_CR42","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1128\/AAC.01010-09","volume":"54","author":"M Ohnishi","year":"2010","unstructured":"Ohnishi M, Watanabe Y, Ono E, Takahashi C, Oya H, Kuroki T, Shimuta K, Okazaki N, Nakayama S, Watanabe H (2010) Spread of a chromosomal cefixime-resistant penA gene among different Neisseria gonorrhoeae lineages. Antimicrob Agents Chemother 54(3):1060\u20131067","journal-title":"Antimicrob Agents Chemother"},{"issue":"7","key":"9809_CR43","doi-asserted-by":"crossref","first-page":"3538","DOI":"10.1128\/AAC.00325-11","volume":"55","author":"M Ohnishi","year":"2011","unstructured":"Ohnishi M, Golparian D, Shimuta K, Saika T, Hoshina S, Iwasaku K, Nakayama S, Kitawaki J, Unemo M (2011) Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea? Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 55(7):3538\u20133545","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"9809_CR44","doi-asserted-by":"crossref","first-page":"4032","DOI":"10.1128\/AAC.00406-09","volume":"53","author":"M Pandori","year":"2009","unstructured":"Pandori M, Barry PM, Wu A, Ren A, Whittington WL, Liska S, Klausner JD (2009) Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California. Antimicrob Agents Chemother 53(9):4032\u20134034","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9809_CR45","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1128\/AAC.00788-10","volume":"55","author":"VG Allen","year":"2011","unstructured":"Allen VG, Farrell DJ, Rebbapragada A, Tan J, Tijet N, Perusini SJ, Towns L, Lo S, Low DE, Melano RG (2011) Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada. Antimicrob Agents Chemother 55(2):703\u2013712","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"9809_CR46","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s10156-012-0450-3","volume":"19","author":"S Takahashi","year":"2012","unstructured":"Takahashi S, Kurimura Y, Hashimoto J, Uehara T, Hiyama Y, Iwasawa A, Nishimura M, Sunaoshi K, Takeda K, Suzuki N, Tsukamoto T (2012) Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan. J Infect Chemother 19(1):50\u201356","journal-title":"J Infect Chemother"},{"issue":"3","key":"9809_CR47","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1128\/AAC.05760-11","volume":"56","author":"M Unemo","year":"2012","unstructured":"Unemo M, Golparian D, Nicholas R, Ohnishi M, Gallay A, Sednaoui P (2012) High-level cefixime- and ceftriaxone-resistant Neisseria gonorrhoeae in France: novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 56(3):1273\u20131280","journal-title":"Antimicrob Agents Chemother"},{"key":"9809_CR48","doi-asserted-by":"crossref","unstructured":"Unemo M, Golparian D, Stary A, Eigentler A (2011) First Neisseria gonorrhoeae strain with resistance to cefixime causing gonorrhoea treatment failure in Austria, 2011. Euro Surveill 16(43):19998","DOI":"10.2807\/ese.16.43.19998-en"},{"issue":"6","key":"9809_CR49","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1128\/AAC.01604-06","volume":"51","author":"R Lindberg","year":"2007","unstructured":"Lindberg R, Fredlund H, Nicholas R, Unemo M (2007) Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime and ceftriaxone: association with genetic polymorphisms in penA, mtrR, porB1b, and ponA. Antimicrob Agents Chemother 51(6):2117\u20132122","journal-title":"Antimicrob Agents Chemother"},{"issue":"14","key":"9809_CR50","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm9700575","volume":"41","author":"M Sandberg","year":"1998","unstructured":"Sandberg M, Eriksson L, Jonsson J, Sjostrom M, Wold S (1998) New chemical descriptors relevant for the design of biologically active peptides. A multivariate characterization of 87 amino acids. J Med Chem 41(14):2481\u20132491","journal-title":"J Med Chem"},{"key":"9809_CR51","unstructured":"Frisch MJ, Trucks GW, Schlegel HB, Scuseria GE, Robb MA, Cheeseman JR, Scalmani G, Barone V, Mennucci B, Petersson GA, Nakatsuji H, Caricato M, Li X, Hratchian HP, Izmaylov AF, Bloino J, Zheng G, Sonnenberg JL, Hada M, Ehara M, Toyota K, Fukuda R, Hasegawa J, Ishida M, Nakajima T, Honda Y, Kitao O, Nakai H, Vreven T, Montgomery JA, Jr., Peralta JE, Ogliaro F, Bearpark M, Heyd JJ, Brothers E, Kudin KN, Staroverov VN, Kobayashi R, Normand J, Raghavachari K, Rendell A, Burant JC, Iyengar SS, Tomasi J, Cossi M, Rega N, Millam NJ, Klene M, Knox JE, Cross JB, Bakken V, Adamo C, Jaramillo J, Gomperts R, Stratmann RE, Yazyev O, Austin AJ, Cammi R, Pomelli C, Ochterski JW, Martin RL, Morokuma K, Zakrzewski VG, Voth GA, Salvador P, Dannenberg JJ, Dapprich S, Daniels AD, Farkas \u00d6, Foresman JB, Ortiz JV, Cioslowski J, Fox DJ (2009). Gaussian 09, Revision A1, Connecticut, Wallingford"},{"issue":"3","key":"9809_CR52","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1021\/cr950202r","volume":"96","author":"M Karelson","year":"1996","unstructured":"Karelson M, Lobanov VS, Katritzky AR (1996) Quantum-chemical descriptors in QSAR\/QSPR studies. Chem Rev 96(3):1027\u20131044","journal-title":"Chem Rev"},{"issue":"1\u20133","key":"9809_CR53","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(00)00129-0","volume":"46","author":"CA Lipinski","year":"2001","unstructured":"Lipinski CA, Lombardo F, Dominy BW, Feeney PJ (2001) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46(1\u20133):3\u201326","journal-title":"Adv Drug Deliv Rev"},{"issue":"10","key":"9809_CR54","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1023\/A:1015040217741","volume":"16","author":"J Kelder","year":"1999","unstructured":"Kelder J, Grootenhuis PD, Bayada DM, Delbressine LP, Ploemen JP (1999) Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs. Pharm Res 16(10):1514\u20131519","journal-title":"Pharm Res"},{"issue":"3","key":"9809_CR55","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1023\/A:1008130001697","volume":"14","author":"TI Oprea","year":"2000","unstructured":"Oprea TI (2000) Property distribution of drug-related chemical databases. J Comput Aided Mol Des 14(3):251\u2013264","journal-title":"J Comput Aided Mol Des"},{"issue":"2","key":"9809_CR56","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/nrd4163","volume":"13","author":"AL Hopkins","year":"2014","unstructured":"Hopkins AL, Keseru GM, Leeson PD, Rees DC, Reynolds CH (2014) The role of ligand efficiency metrics in drug discovery. Nat Rev Drug Discov 13(2):105\u2013121","journal-title":"Nat Rev Drug Discov"},{"issue":"9","key":"9809_CR57","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1128\/AAC.00304-09","volume":"53","author":"S Zhao","year":"2009","unstructured":"Zhao S, Duncan M, Tomberg J, Davies C, Unemo M, Nicholas RA (2009) Genetics of chromosomally mediated intermediate resistance to ceftriaxone and cefixime in Neisseria gonorrhoeae. Antimicrob Agents Chemother 53(9):3744\u20133751","journal-title":"Antimicrob Agents Chemother"},{"key":"9809_CR58","unstructured":"Eriksson L, Byrne T, Johansson E, Trygg J, Vikstr\u00f6m C (2013) Multi- and megavariate data analysis: basic principles and applications, 3rd edn. Umetrics Academy, Malm\u00f6"},{"key":"9809_CR59","unstructured":"Umetrics AB (2005) User\u2019s guide to SIMCA-P, SIMCA-P+. Umetrics AB, Ume\u00e5"},{"key":"9809_CR60","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1471-2105-6-50","volume":"6","author":"E Freyhult","year":"2005","unstructured":"Freyhult E, Prusis P, Lapinsh M, Wikberg JE, Moulton V, Gustafsson MG (2005) Unbiased descriptor and parameter selection confirms the potential of proteochemometric modelling. BMC Bioinform 6:50","journal-title":"BMC Bioinform"},{"issue":"1\u20132","key":"9809_CR61","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0169-7439(00)00113-1","volume":"55","author":"A H\u00f6skuldsson","year":"2001","unstructured":"H\u00f6skuldsson A (2001) Variable and subset selection in PLS regression. Chemom Intell Lab Syst 55(1\u20132):23\u201338","journal-title":"Chemom Intell Lab Syst"},{"issue":"1","key":"9809_CR62","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/qsar.200390007","volume":"22","author":"A Tropsha","year":"2003","unstructured":"Tropsha A, Gramatica P, Gombar VK (2003) The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models. QSAR Comb Sci 22(1):69\u201377","journal-title":"QSAR Comb Sci"},{"issue":"10","key":"9809_CR63","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1289\/ehp.5758","volume":"111","author":"L Eriksson","year":"2003","unstructured":"Eriksson L, Jaworska J, Worth AP, Cronin MT, McDowell RM, Gramatica P (2003) Methods for reliability and uncertainty assessment and for applicability evaluations of classification- and regression-based QSARs. Environ Health Perspect 111(10):1361\u20131375","journal-title":"Environ Health Perspect"},{"issue":"7","key":"9809_CR64","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/ci900115y","volume":"49","author":"V Consonni","year":"2009","unstructured":"Consonni V, Ballabio D, Todeschini R (2009) Comments on the definition of the Q2 parameter for QSAR validation. J Chem Inf Model 49(7):1669\u20131678","journal-title":"J Chem Inf Model"},{"issue":"12","key":"9809_CR65","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1517\/17460441.2.12.1567","volume":"2","author":"K Roy","year":"2007","unstructured":"Roy K (2007) On some aspects of validation of predictive quantitative structure-activity relationship models. Expert Opin Drug Discov 2(12):1567\u20131577","journal-title":"Expert Opin Drug Discov"},{"issue":"7","key":"9809_CR66","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1128\/AAC.00093-13","volume":"57","author":"J Tomberg","year":"2013","unstructured":"Tomberg J, Unemo M, Ohnishi M, Davies C, Nicholas RA (2013) Identification of amino acids conferring high-level resistance to expanded-spectrum cephalosporins in the penA gene from Neisseria gonorrhoeae strain H041. Antimicrob Agents Chemother 57(7):3029\u20133036","journal-title":"Antimicrob Agents Chemother"},{"issue":"11","key":"9809_CR67","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1128\/AAC.00743-07","volume":"51","author":"M Yamada","year":"2007","unstructured":"Yamada M, Watanabe T, Miyara T, Baba N, Saito J, Takeuchi Y, Ohsawa F (2007) Crystal structure of cefditoren complexed with Streptococcus pneumoniae penicillin-binding protein 2X: structural basis for its high antimicrobial activity. Antimicrob Agents Chemother 51(11):3902\u20133907","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"9809_CR68","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1006\/jmbi.2000.3740","volume":"299","author":"E Gordon","year":"2000","unstructured":"Gordon E, Mouz N, Duee E, Dideberg O (2000) The crystal structure of the penicillin-binding protein 2x from Streptococcus pneumoniae and its acyl-enzyme form: implication in drug resistance. J Mol Biol 299(2):477\u2013485","journal-title":"J Mol Biol"},{"issue":"3","key":"9809_CR69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/bi027019u","volume":"42","author":"S Muzammil","year":"2003","unstructured":"Muzammil S, Ross P, Freire E (2003) A major role for a set of non-active site mutations in the development of HIV-1 protease drug resistance. Biochemistry 42(3):631\u2013638","journal-title":"Biochemistry"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-014-9809-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-014-9809-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,20]],"date-time":"2022-04-20T17:18:36Z","timestamp":1650475116000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-014-9809-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,26]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["9809"],"URL":"https:\/\/doi.org\/10.1007\/s10822-014-9809-0","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,10,26]]}}}